SAFE-BioPharma, LLC Standard to be Highlighted at Molecular TriCon
2/3/2012 7:03:06 AM
FORT LEE, N.J.--(BUSINESS WIRE)--The role of SAFE-BioPharma interoperable digital identities in assuring secure cloud computing will be featured at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference, Sunday, February 19, at Moscone Center in San Francisco. The Molecular Medicine Tri-Conference is one of the key life science industry meetings covering the latest trends, technologies, research breakthroughs, regulatory issues, and best practice examples of molecular and translational medicine advances.
comments powered by